Q3 2024 net sales rose 19% to SEK 512M, driven by Thebalux acquisition and strong UK/NL performance. EBITA margin improved to 13.9%, while leverage increased to 2.3x EBITDA. Nordic markets remained challenging.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.